In addition to NMDARs themselves, downstream molecules of NMDARs are also targets of drug design, and inhibiting nNOS showed protective effects in Alzheimer's disease model mice (Misra, Kuhad & Chopra, 2013; Yu et al., 2013). Here, NOS1 is linked to early-onset autosomal dominant Alzheimer disease.